OxyContin, the FDA, and Drug Control

AMA journal of ethics - United States
doi 10.1001/virtualmentor.2014.16.4.pfor1-1404
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

American Medical Association (AMA)

Related search

OxyContin® as Currency: OxyContin® Use and Increased Social Capital Among Rural Appalachian Drug Users

Social Science and Medicine
MedicinePhilosophy of ScienceHealthHistory
2012English

Drug Diversion of Oxycontin in Chronic Pain Syndrome

Irish Journal of Psychological Medicine
PsychiatryMental HealthPhilosophy of ScienceApplied PsychologyHistory
2006English

2017 FDA Drug Approvals

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2018English

From the FDA: Epilepsy Drug Approved

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1994English

From the FDA: FDA Issues Final Rule on Drug Products Containing Colloidal Silver

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1999English

Serious Adverse Drug Events Reported to the Food and Drug Administration (FDA): Analysis of the FDA Adverse Event Reporting System (FAERS) 2006-2011 Database

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

OxyContin and Neonatal Abstinence Syndrome

Journal of Perinatology
GynecologyChild HealthPediatricsPerinatologyObstetrics
2002English

The UCSF-FDA TransPortal: A Public Drug Transporter Database

Clinical Pharmacology and Therapeutics
Pharmacology
2012English

Measuring the Impact of the Food and Drug Administration (Fda) Unapproved Drug Initiative (Udi) on Drug Prices and Expenditures

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy